David Raben
大卫·拉本
MD
Professor, Department of Radiation Oncology; Head and Neck/Lung Disease Group Leader放射肿瘤学系教授；头颈部/肺部疾病组长
👥Biography 个人简介
David Raben is a radiation oncologist and translational researcher at the University of Colorado Cancer Center specializing in SBRT for thoracic malignancies and molecularly targeted radiosensitization. He has translated EGFR and VEGFR inhibitor findings into cooperative group clinical trials.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
SBRT for Thoracic Malignancies
Advanced SBRT dose-fractionation protocols for early-stage and central lung tumors, contributing to national practice guidelines.
EGFR Inhibitor + Radiation Synergy
Led preclinical and clinical studies demonstrating synergy between EGFR inhibitors and radiation in head and neck and lung cancer.
NRG/RTOG Cooperative Trials
Co-developed multi-institutional clinical trials testing molecularly targeted radiosensitization in thoracic and head and neck malignancies.
Representative Works 代表性著作
Antitumor activity of ZD6474 combined with radiation in preclinical lung cancer models
Clinical Cancer Research (2004)
Demonstrated VEGFR inhibition plus radiation produces supra-additive tumor growth delay in preclinical lung models.
RTOG 0617: randomized phase III comparison of high-dose vs standard-dose RT for NSCLC
Journal of Clinical Oncology (2015)
Landmark trial contributing to dose prescribing standards in locally advanced NSCLC.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Brian Marples
University of Rochester Medical Center
Silvia C. Formenti
Weill Cornell Medicine / NewYork-Presbyterian Hospital
Paul M. Harari
University of Wisconsin School of Medicine and Public Health
Jeff Forman
Wayne State University / Karmanos Cancer Institute
关注 大卫·拉本 的研究动态
Follow David Raben's research updates
留下邮箱，当我们发布与 David Raben（University of Colorado School of Medicine）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment